Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comparison Between Socket Shield and Conventional Techniques in Immediate Implant Placement.

10. august 2026 oppdatert av: Omar Ibrahim Wahedi, Minia University

Comparative Study Between Using Socket Shield And Conventional Techniques In Immediate Implant Placement (A Randomized Clinical Trial)

The goal of this randomized clinical trial is to compare whether immediate implant placement using the socket-shield technique can better preserve bone density, bone level, and peri-implant tissue health compared to conventional immediate implant placement in patients requiring tooth extraction in the maxillary esthetic zone.

This study is conducted in systemically healthy adult patients aged 20-60 years who have non-restorable maxillary anterior teeth indicated for immediate implant placement.

The main questions this study aims to answer are:

Does the socket-shield technique result in better peri-implant bone density and bone level preservation compared to the conventional immediate implant technique?

Does the socket-shield technique lead to improved clinical peri-implant parameters, including probing depth, bleeding on probing, keratinized tissue width, and soft tissue thickness?

participants will be divided into two groups: (both groups will receive immediate implant placement of a tooth requiring extraction in the maxillary esthetic zone.) First group: will recieve immediate implant using conventional technique. second group: will recieve immediate implant using socket shield technique.

Participants will:

  • Undergo clinical and radiographic examinations, including cone beam computed tomography (CBCT).
  • Receive immediate implant placement using either the conventional technique or the socket-shield technique.
  • Be followed up clinically and radiographically for 9 months to assess bone and soft tissue healing.
  • Attend regular postoperative and follow-up visits for evaluation of implant stability and peri-implant tissue health.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

16

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

  • Egypt
      • Minya, Egypt
        • Rekruttering
        • Minia University
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Patients aged between 20 and 60 years of both genders
  • All participants should be systemically healthy, as assessed using the dental modification of the Cornell Medical Index.
  • Gingival and periodontal health to be confirmed according to the criteria outlined in the new classification system proposed by Caton et al. (2018).
  • Presence of non-restorable teeth due to trauma, complicated crowns or root fractures.
  • Presence of extensive destructive caries making the tooth unsalvageable, particularly in esthetic zones.
  • Clinical indication for immediate implant placement, especially in cases where minimizing post-extraction bone resorption and soft tissue collapse is critical.
  • Availability of adequate interocclusal space to accommodate the necessary prosthetic components without occlusal interference.

Exclusion Criteria:

(for socket-shield technique)

  • Pregnant female.
  • Patients with parafunctional habits (e.g., bruxism, clenching).
  • Smokers.
  • Teeth with clinical mobility.
  • Teeth with root fractures extending below the alveolar bone level.
  • Periodontal ligament space widening.
  • Signs of internal or external root resorption.
  • Current or previous periodontal disease

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: GROUP I
Immediate Implant Placement Using Conventional Technique
Fremgangsmåte: Conventional Technique
Immediate Implant Placement Using Conventional Technique
Eksperimentell: GROUP II
Immediate Implant Placement Using Socket-Shield Technique
Fremgangsmåte: Socket-Shield Technique
Immediate Implant Placement Using Socket-Shield Technique

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Bone Density Around Immediate Implants.
Tidsramme: At baseline of implant placement then after 9 months

Assessment of bone mineral density using Gray scale values (GSV) derived from Cone Beam Computed Tomography (CBCT) scans. Measurements will be evaluated at the buccal bone adjacent to the retained root fragment (Socket Shield Group) and adjacent to the implant surface (Conventional Immediate Placement Group). The change will be calculated by subtracting the baseline value from the 9-month follow-up value.

Unit of Measure: Gray scale values Time Frame: Baseline to 9 months post-implant placement

Measure Description:

Bone density measured using average gray values extracted from CBCT DICOM files at the buccal aspect of the implant site. Gray scale values reflect the radiographic attenuation/pixel intensity of the surrounding bone.
At baseline of implant placement then after 9 months
Change in Marginal Bone Level Around Immediate Implants.
Tidsramme: At baseline of implant placement then after 9 months.
  • Linear measurement of the distance from the implant platform to the first bone-to-implant contact point to assess crestal bone stability.
  • Unit of measure : Millimeters (mm).
At baseline of implant placement then after 9 months.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Probing Depth (PD)
Tidsramme: 3 months, 6 months, and 9 months post-surgery.

Measurement of the distance from the peri-implant mucosal margin to the bottom of the clinical pocket using a calibrated periodontal probe.

Unit of Measure: Millimeters (mm)
3 months, 6 months, and 9 months post-surgery.
Modified Gingival Index (MGI)
Tidsramme: 3 months, 6 months, and 9 months post-surgery.

Assessment of the visual signs of inflammation of the peri-implant soft tissues. Scores range from 0 to 4 (0 = Normal, 1 = Mild inflammation, 2 = Mild inflammation with color change, 3 = Moderate inflammation, 4 = Severe inflammation).

Unit of Measure: Score on a scale (0-4)
3 months, 6 months, and 9 months post-surgery.
Modified Plaque Index (MPI)
Tidsramme: 3 months, 6 months, and 9 months post-surgery.

Assessment of the amount of plaque on the implant/restoration surface. Scores range from 0 to 3 :

  • 0 = No plaque
  • 1 = Plaque only recognized by running a probe
  • 2 = Plaque visible to the naked eye
  • 3 = Abundance of soft matter).

Unit of Measure: Score on a scale (0-3)
3 months, 6 months, and 9 months post-surgery.
Gingival Thickness (GT)
Tidsramme: Baseline, 3 months, 6 months, and 9 months post-surgery.

Assessment of the thickness of the peri-implant mucosa. This will be measured using a digital caliper or endodontic file with a rubber stopper 2mm apical to the gingival margin.

Unit of Measure: Millimeters (mm)
Baseline, 3 months, 6 months, and 9 months post-surgery.
Width of Keratinized Tissue (KTW)
Tidsramme: Baseline, 3 months, 6 months, and 9 months post-surgery.

Measured from the gingival margin to the mucogingival junction at the mid-facial aspect of the implant site.

Unit of Measure: Millimeters (mm)
Baseline, 3 months, 6 months, and 9 months post-surgery.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Minia University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

20. oktober 2025

Primær fullføring (Antatt)

1. oktober 2026

Studiet fullført (Antatt)

1. november 2026

Datoer for studieregistrering

Først innsendt

15. desember 2025

Først innsendt som oppfylte QC-kriteriene

10. august 2026

Først lagt ut (Faktiske)

12. august 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

10. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • MU-EC Research No.1187

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere